Aenova Holding GmbHAenova is one of the leading contract development and manufacturing organizations (CDMOs) in the global pharmaceutical supply chain. They provide services covering the entire value chain from development to commercialization for all common product groups and dosage forms (solid, semisolid, sterile, and nonsterile liquid). The company supplies drugs up to OEB 5 and food supplements for both human and veterinary use. They are also able to handle differentiated technologies such as HPAPI containment, low-dose, modified release formulations, organic granulation, particulate systems, lipid-based formulas, HME or spray drying for poorly soluble compounds.Aenova offers customers a wide-ranging service portfolio and challenges itself to expedite time to market and facilitate the drug development journey. The one-stop-shop experience stretches from early phase formulation and product development to the purchase of raw materials, analytics, regulatory support, small and full-scale production, market release through to packaging and logistics. Aenova develops, produces and packages across a network of 14 sites in the US, Germany, Switzerland, Italy, Ireland, and Romania, with headquarters near Munich, Germany. The manufacturing sites are complemented by seven specialized Development Competence Centers for various technologies and dosage forms that support clients with tailormade solutions.
